JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Essential role of postoperative follow-up in the management of clear cell sarcoma

  • 0Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
World Journal of Clinical Cases +

|

August 19, 2024

|

August 19, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Clear cell sarcoma (CCS), a rare cancer, often has a poor prognosis and spreads to lymph nodes. Long-term patient follow-up is crucial for managing this challenging soft tissue sarcoma.

Area Of Science

  • Oncology
  • Pathology

Background

  • Clear cell sarcoma (CCS) is a rare melanocytic soft tissue sarcoma.
  • CCS is characterized by a propensity for lymph node metastasis and an unfavorable prognosis.

Discussion

  • Current treatment for localized CCS involves surgical resection; radiotherapy and chemotherapy are used for metastatic disease.
  • The roles of adjuvant chemotherapy, radiotherapy, and lymph node dissection in CCS management remain controversial.
  • Immunotherapy presents a promising research avenue for CCS, but clinical standards for postoperative follow-up are lacking.

Key Insights

  • This editorial reviews diagnostic modalities, treatment strategies, and prognostic challenges in clear cell sarcoma.
  • It emphasizes the critical need for comprehensive, long-term patient follow-up in CCS management.

Outlook

  • Further research is needed to establish clear clinical guidelines for postoperative follow-up in clear cell sarcoma.
  • Investigating the efficacy of immunotherapy and refining treatment protocols are essential for improving patient outcomes.

Keywords: